COVID-19 Vaccine Update: India’s Drug Control General gives final approval to Covidshield, Covaxin
 |
| Supervisory General of Drugs Control in India Gives Final Approval of Covishiled , Covaxine |
Supervisory General of Drugs in India
New Delhi: The Drug Administration in India on Sunday finally approved the Oxford vaccine in India under the names Covishield and Covaxin for Bharat Biotech. This makes them the first vaccine approved.
#WATCH: Drugs Controller General of India briefs the media on COVID-19 vaccine. https://t.co/0PhAeVzOgC
— ANI (@ANI) January 3, 2021
This is because on Saturday a group of experts from the Central Indian Drug Authority recommended the General Controller for Medicines in India to approve the limited use of the local Covid-19 Covaxin vaccine developed by Bharat Biotech in an emergency, particularly in connection with infections. of the mutant strain.
Bharat Biotech’s vaccine recommendation comes a day after the Thematic Committee of the Central Organization for Drug Control (SEC) approved the Oxford-AstraZeneca application for approval of the emergency use of the Indian Serum Institute for Covishield vaccine.
According to the official announcement, the SEC met on Friday and Saturday and made its recommendations regarding expedited approval applications from SII, Bharat Biotech International Ltd, and Cadi
#WATCH I We’ll never approve anything if there’s slightest of safety concern. Vaccines are 110 % safe. Some side effects like mild fever, pain & allergy are common for every vaccine. It (that people may get impotent) is absolute rubbish: VG Somani,Drug Controller General of India pic.twitter.com/ZSQ8hU8gvw
— ANI (@ANI) January 3, 2021
la Healthcare Ltd. Phase III testing. from.
The panel of experts recommended that the Serum Institute in India, Pune, approve limited emergency use of vaccines under a number of regulatory provisions.